Presentation TCT 2014 Rivaroxaban in ACS and Atrial Fibrillation: Randomized Trials, Real-World Data, and Pioneering Efforts Presenter: C. Michael Gibson September 15, 2014 REGISTER for free or LOG IN to view this content Coronary Presentation TCT 2014 Up Next Presentation TCT 2015 TCT 23: Patients, Lesion Characteristics, and Procedural Outcome Against Interventional Revascularization on Chronic Total Occlusion of Prior Coronary Artery Bypass Graft Surgery Presenter: Masaki Tanabe October 13, 2015 More slides + Presentation TCT 2015 TCT 64: Incidence, Predictors, and Impact of Postdischarge Bleeding Compared to Myocardial Infarction After Percutaneous Coronary Intervention Presenter: Philippe Généreux October 13, 2015 Presentation TCT 2014 BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) ? 2 Year___ Presenter: Rafael Ruiz-Salmeron September 16, 2014 We Recommend
Presentation TCT 2015 TCT 23: Patients, Lesion Characteristics, and Procedural Outcome Against Interventional Revascularization on Chronic Total Occlusion of Prior Coronary Artery Bypass Graft Surgery Presenter: Masaki Tanabe October 13, 2015
Presentation TCT 2015 TCT 64: Incidence, Predictors, and Impact of Postdischarge Bleeding Compared to Myocardial Infarction After Percutaneous Coronary Intervention Presenter: Philippe Généreux October 13, 2015
Presentation TCT 2014 BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) ? 2 Year___ Presenter: Rafael Ruiz-Salmeron September 16, 2014